{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System - Ampicillin 0.5-32 \u03bcg/mL E",
        "BD Phoenix\u2122M Automated Microbiology System for use with Ampicillin 0.5-32 \u03bcg/mL - Gram-negative ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K061355",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K032299"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "May 12, 2006",
    "Summary Letter Received Date": "May 15, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ampicillin"
    ],
    "Specimen Type(s)": [
        "Isolates from pure culture of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria of human origin"
    ],
    "Specimen Container(s)": [
        "Phoenix panels (molded polystyrene tray with micro-wells)"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument",
        "BD Phoenix panels"
    ],
    "Method(s)/Technology(ies)": [
        "Broth based microdilution test",
        "Redox indicator for growth detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System using Ampicillin for AST of aerobic and facultative anaerobic bacteria isolates",
    "Indications for Use Summary": "For rapid identification and in vitro antimicrobial susceptibility testing by MIC of isolates from pure culture of most Gram-negative aerobic and facultative anaerobic bacteria, including Enterobacteriaceae and Non-Enterobacteriaceae, and Gram-positive isolates from Staphylococcus, Enterococcus, and Streptococcus, using Ampicillin panels",
    "fda_folder": "Microbiology"
}